PROVIDER PROFILE · NPI 1346410214

Elsa Delille

Nurse PractitionerNew York, NYI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

Beneficiaries

—

Total drug cost

$757K

Distinct drugs

Brand share

56.6%

Top prescribed drugs

Hydroxyurea36 claims

Ruxolitinib Phosphate35 claims

Decitabine/Cedazuridine12 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$212

Payment records

By payment type

Food and Beverage$212

REFERRAL NETWORK

Where Elsa Delille's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
NYU LANGONE HOSPITALS	21	157
David Kaminetzky Medical Oncology · New York, NY	14	205

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
NYU LANGONE HOSPITALS	25	215
NYU LANGONE HOSPITALS	16	51
David Kaminetzky Medical Oncology · New York, NY	13	154
Catherine Diefenbach Medical Oncology · New York, NY	13	127

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history